Context Capital Management’s BioPlus Acquisition Corp. Warrants BIOSW Stock Holding History

Context Capital Management’s Portfolio BIOSW Stock Details BIOSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-105,069	Closed	-$6K	–	314
2023 Q3	$6K	Hold	105,069	–	–	﹤0.01%	243
2023 Q2	$15K	Hold	105,069	–	–	﹤0.01%	186
2023 Q1	$9K	Hold	105,069	–	–	﹤0.01%	271
2022 Q4	$5K	Hold	105,069	–	–	﹤0.01%	365
2022 Q3	$14K	Hold	105,069	–	–	﹤0.01%	446
2022 Q2	$15K	Hold	105,069	–	–	﹤0.01%	485
2022 Q1	$24K	Buy	+105,069	New	+$27.3K	﹤0.01%	567

Context Capital Management's BIOSW Position: Q4 2023 in Review

Context Capital Management sold out of BioPlus Acquisition Corp. Warrants (BIOSW) in Q4 2023, closing a stake of 105,069 shares — an estimated $6K sold.

Context Capital Management first reported a position in BIOSW in Q1 2022 and held it in 7 quarters. The position peaked at $24K in Q1 2022. 0 funds tracked by Wall St. Rank hold BIOSW as of Q4 2023.

Context Capital Management reported no remaining BioPlus Acquisition Corp. Warrants position as of Q4 2023 after selling out during the quarter.
Context Capital Management sold 105,069 BioPlus Acquisition Corp. Warrants shares in Q4 2023, an estimated $6K.
Context Capital Management first reported a position in BioPlus Acquisition Corp. Warrants in Q1 2022 and held it in 7 quarters.
Context Capital Management's BioPlus Acquisition Corp. Warrants position peaked at $24K in Q1 2022.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Warrants as of Q4 2023.

Based on Context Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.